TEPA de META TV reçoit Pierre Hillard pour Comprendre le Nouvel Ordre Mondial. 05 Janvier 2014. Partie 2/6. "Si vous écoutez ce message, c'est que vous êtes la résistance". Partie 1/6 : https://odysee.com/@ArchivesDuCovidisme:6/Comprendre_le_nouvel_ordre_mondial_avec_Pierre_Hillard_sur_la_libre_antenne_de_Meta_TV_16_2014Janvier5hd:8?r=CbYkMQHhjYgE3JvqCytiazypwjxpaF1y Partie 2/6 : https://odysee.com/@ArchivesDuCovidisme:6/Comprendre_le_nouvel_ordre_mondial_avec_Pierre_Hillard_sur_la_libre_antenne_de_Meta_TV__26_2014Janvier5:4?r=CbYkMQHhjYgE3JvqCytiazypwjxpaF1y Partie 3/6 : https://odysee.com/@ArchivesDuCovidisme:6/Comprendre_le_nouvel_ordre_mondial_avec_Pierre_Hillard_sur_la_libre_antenne_de_Meta_TV__36_2014Janvier5:a?r=CbYkMQHhjYgE3JvqCytiazypwjxpaF1y Partie 4/6 : https://odysee.com/@ArchivesDuCovidisme:6/Comprendre_le_nouvel_ordre_mondial_avec_Pierre_Hillard_sur_la_libre_antenne_de_Meta_TV_46_2014Janvier5:6?r=CbYkMQHhjYgE3JvqCytiazypwjxpaF1y Partie 5/6 : https://odysee.com/@ArchivesDuCovidisme:6/Comprendre_le_nouvel_ordre_mondial_avec_Pierre_Hillard_sur_la_libre_antenne_de_Meta_TV__56_2014Janvier5:8?r=CbYkMQHhjYgE3JvqCytiazypwjxpaF1y Partie 6/6 : https://odysee.com/@ArchivesDuCovidisme:6/Comprendre_le_nouvel_ordre_mondial_avec_Pierre_Hillard_sur_la_libre_antenne_de_Meta_TV__66_2014Janvier5:0?r=CbYkMQHhjYgE3JvqCytiazypwjxpaF1y

Resterez-vous confiné toute votre vie? https://www.infovac.ch/fr/infovac/actualites/955-vaccins-contre-le-covid-19-liste-des-essais-cliniques Vaccins à ARNm: GeneOne Life Sciences: https://clinicaltrials.gov/ct2/show/NCT04673149 Providence Health & Sciences: https://clinicaltrials.gov/ct2/show/NCT04627675 Entos Pharmaceuticals: https://clinicaltrials.gov/ct2/show/NCT04591184 Université Chulalongkorn: https://clinicaltrials.gov/ct2/show/NCT04566276 Arcturus Therapeutics: https://clinicaltrials.gov/ct2/show/NCT04480957 AnGes: https://clinicaltrials.gov/ct2/show/NCT04463472 Genexine: https://clinicaltrials.gov/ct2/show/NCT04445389 CureVac AG: https://clinicaltrials.gov/ct2/show/NCT04449276?cond=COVID-19&phase=0&draw=3 Novavax: https://www.clinicaltrials.gov/ct2/show/NCT04368988 Moderna: https://clinicaltrials.gov/ct2/show/NCT04283461?term=vaccine&cond=covid-19&draw=2 Pfizer: https://clinicaltrials.gov/ct2/show/NCT04368728 https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE Yunnan Walvax: http://www.chictr.org.cn/showprojen.aspx?proj=55524 Inovio Pharmaceuticals: https://clinicaltrials.gov/ct2/show/NCT04336410?type=Intr&cond=COVID-19&phase=014&draw=3 Vaccins à Vecteur: Astrazeneca: https://clinicaltrials.gov/ct2/show/NCT04516746 Janssen: https://clinicaltrials.gov/ct2/show/NCT04436276?term=NCT04436276&draw=2&rank=1 CanSino: http://www.chictr.org.cn/showprojen.aspx?proj=52006 Spoutnik Gamaleya: https://clinicaltrials.gov/ct2/show/NCT04436471?term=vaccine&cond=COVID-19&phase=0&draw=2 Spoutnik Gamaleya: https://clinicaltrials.gov/ct2/show/NCT04437875?term=vaccine&cond=COVID-19&phase=0&draw=2 Merck Sharp & Dohme Corp: https://www.clinicaltrials.gov/ct2/show/NCT04498247 Merck Sharp & Dohme Corp: https://clinicaltrials.gov/ct2/show/NCT04569786 Institut Pasteur: https://clinicaltrials.gov/ct2/show/NCT04497298?term=04497298&draw=2&rank=1 ReïThera: https://www.clinicaltrials.gov/ct2/show/NCT04528641?term=NCT04528641&draw=2&rank=1 Vaxart: https://clinicaltrials.gov/ct2/show/NCT04563702?term=NCT04563702&draw=2&rank=1 Université d'Hambourg: https://clinicaltrials.gov/ct2/show/NCT04569383 ImmunityBio: https://clinicaltrials.gov/ct2/show/NCT04591717 Institut Israëlien: https://www.clinicaltrials.gov/ct2/show/NCT04608305 City of Hope: https://clinicaltrials.gov/ct2/show/NCT04639466 Cellid: https://clinicaltrials.gov/ct2/show/NCT04666012 Vaccins Sous Unitaires - Purifiés: Novavax: https://clinicaltrials.gov/ct2/show/NCT04368988?cond=COVID-19&phase=0&draw=2 Clover Bioph: https://clinicaltrials.gov/ct2/show/NCT04405908?term=CpG+1018&draw=2 Université du Queensland: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379861&isReview=true Medicago: https://clinicaltrials.gov/ct2/show/NCT04450004?term=vaccine&cond=COVID-19&phase=0&draw=2 Longcom: https://clinicaltrials.gov/ct2/show/NCT04445194?term=longcom&draw=2 Kentucky BioProcessing: https://clinicaltrials.gov/ct2/show/NCT04473690?term=NCT04473690&draw=2&rank=1 Medigene Vaccine: https://www.clinicaltrials.gov/ct2/show/NCT04695652 Adimmune Corporation: https://clinicaltrials.gov/ct2/show/NCT04522089 Vector: https://www.clinicaltrials.gov/ct2/show/NCT04527575 SanofiPasteur: https://clinicaltrials.gov/ct2/show/NCT04537208 Jiangsu: https://clinicaltrials.gov/ct2/show/NCT04530656?term=NCT04530656&draw=2&rank=1 Covaxx: https://clinicaltrials.gov/ct2/show/NCT04683224 Université de Tuebingen: https://clinicaltrials.gov/ct2/show/NCT04546841?term=04546841&draw=2&rank=1 Soberana: https://rpcec.sld.cu/en/trials/RPCEC00000332-En Nanogen: https://www.clinicaltrials.gov/ct2/show/NCT04683484 Université du Saskatchewan: https://clinicaltrials.gov/ct2/show/NCT04702178 SK Biosciences: https://clinicaltrials.gov/ct2/show/NCT04742738 Vaccins Inactivés: Sinovac & Butatan: https://clinicaltrials.gov/ct2/show/NCT04352608?cond=COVID-19&phase=0&draw=2 Qihan Li: https://clinicaltrials.gov/ct2/show/NCT04412538?cond=COVID-19&phase=0&draw=2 Henan CDC: http://www.chictr.org.cn/showprojen.aspx?proj=52227 Bharat Biotech: http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=45184&EncHid=&userName=bbv152 Beijing Institute: http://www.chictr.org.cn/showproj.aspx?proj=53003 QazCovidin: https://www.clinicaltrials.gov/ct2/show/NCT04530357?term=NCT04530357&draw=2&rank=1 Jiangsu CDC: http://www.chictr.org.cn/showprojen.aspx?proj=62350 Valneva: https://clinicaltrials.gov/ct2/show/NCT04671017 Institut de Santé de Turquie: https://clinicaltrials.gov/ct2/show/NCT04691947 Autres Approches de Vaccination: Aivita Biomedical: https://clinicaltrials.gov/ct2/show/NCT04386252?term=aivita&draw=2 Takeda: https://clinicaltrials.gov/ct2/show/NCT04677660 Vaccinations passives, transfert d'anticorps: Immunitor: https://clinicaltrials.gov/ct2/show/NCT04380532?term=immunitor&draw=2 Vaccins à cellules recombinantes: Institut de Shenzhen: https://clinicaltrials.gov/ct2/show/NCT04276896?cond=COVID-19&phase=0&draw=3 Institut de Shenzhen 2 : https://clinicaltrials.gov/ct2/show/NCT04299724?cond=COVID-19&pha